EARNINGSLululemon (LULU) cuts full-year outlook for fourth time as Americas comparable sales drop 12%Sep 7CMCTCMCT logs three preferred-to-common conversions in August and September as VWAP conversion price climbs to $4.55Sep 7SOUNSoundHound AI closes LivePerson acquisition, adding 25 Fortune 100 accounts to SOUN's baseSep 6AAPLPhil Schiller's App Store exit tied to recurring-revenue friction with CEO John TernusSep 6AIRTAir T expands Alerus revolving line to $25 million, extends facility through 2029Sep 6DEALSMinority stake deal puts Constellation Wealth Capital into Confluence Financial's $7.6bn bookSep 6$NEARProtagonist Therapeutics posts $162.8 million Q2 profit as rusfertide awaits FDA rulingSep 6AMZNGuliKit's Switch 2 dock at $29.99 targets travelers after Nintendo breaks third-party compatibilitySep 6DEALSFEAMZX declares USD 12.4706 cash dividend, payment completed September 4Sep 6ENERGYSondland calls on NATO to flip Russia attribution doctrine, presume Kremlin responsible for hybrid attacksSep 6EARNINGSLululemon (LULU) cuts full-year outlook for fourth time as Americas comparable sales drop 12%Sep 7CMCTCMCT logs three preferred-to-common conversions in August and September as VWAP conversion price climbs to $4.55Sep 7SOUNSoundHound AI closes LivePerson acquisition, adding 25 Fortune 100 accounts to SOUN's baseSep 6AAPLPhil Schiller's App Store exit tied to recurring-revenue friction with CEO John TernusSep 6AIRTAir T expands Alerus revolving line to $25 million, extends facility through 2029Sep 6DEALSMinority stake deal puts Constellation Wealth Capital into Confluence Financial's $7.6bn bookSep 6$NEARProtagonist Therapeutics posts $162.8 million Q2 profit as rusfertide awaits FDA rulingSep 6AMZNGuliKit's Switch 2 dock at $29.99 targets travelers after Nintendo breaks third-party compatibilitySep 6DEALSFEAMZX declares USD 12.4706 cash dividend, payment completed September 4Sep 6ENERGYSondland calls on NATO to flip Russia attribution doctrine, presume Kremlin responsible for hybrid attacksSep 6

Inspire Medical Systems adds AtriCure CEO Michael Carrel to board in July 20 appointment

A board seat at Inspire Medical Systems (NYSE: INSP) is in focus after the company's directors named Michael H. Carrel, the sitting president and chief executive of AtriCure, Inc. (NASDAQ: ATRC), as a Class III director on July 20, 2026…

By Grant HalloranMacro DeskJuly 24, 20262 min readINSP
Share